Gene Control Startup Concinnity Secures £3M Seed Funding to Advance Gene Therapy Safety

基因控制初创公司 Concinnity 获得 300 万英镑种子资金

关键词：

来源：

Concinnity Genetics

来源地址：

https://www.synbiobeta.com/read/gene-control-startup-concinnity-secures-ps3m-seed-funding-to-advance-gene-therapy-safety

资源所属：

马铃薯基因组设计育种

类型：

科研项目

语种：

英语

原文发布日期：

2024-12-16

摘要：

Concinnity Genetics, an Edinburgh-based company specializing in gene control, has successfully completed an oversubscribed £3 million seed funding round. The funding was spearheaded by Eos Advisory, with contributions from Scottish Enterprise, Old College Capital (OCC)—the University of Edinburgh’s venture investment fund—and Maven Capital Partners. Co-founded by Jessica Birt and Dr. Matthew Dale, Concinnity aims to enhance the safety of gene therapies through innovative RNA-based control systems. Using a proprietary AI platform combined with synthetic biology expertise, these systems allow precise regulation of gene therapies post-administration, offering the ability to mitigate side effects dynamically.